PAX3 and cancer: Our data are consistent with some other models of metastatic and/or more aggressive cancers exemplifying tumor promoting genes like urokinase plasminogen activator (uPA), PAX3 and Ezrin that are less methylated and/or more highly expressed in the more aggressive cancer forms (40,44,45).